Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > It took a lot of time and money to confirm that excess sugar

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Feb 07, 2021 1:25pm

199 Views

Post# 32496099

RE:RE:RE:It took a lot of time and money to confirm that excess sugar

Stanem yes TD1 is an autoimmune disease but the cause is unknown. It appears to be a combo of genetics and environmental factors. Inuit that historically consumed very low sugar diets actually have high rates of TD1 and the geographic distribution appears to increase with higher latitudes some suggest sunlight exposure. I have a good friend with td1 who grew up in a very healthy household basically eating out of the garden. He does however have TD1 running in the family. Type 2 yes.

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?